Improving Genomic Epidemiology Methodologies and Practice through Interdisciplinary Data Integration and Analysis.
- Funded by Canadian Institutes of Health Research (CIHR)
- Total publications:0 publications
Grant number: 473768
Grant search
Key facts
Disease
COVID-19, Disease Xstart year
2022Known Financial Commitments (USD)
$65,793.1Funder
Canadian Institutes of Health Research (CIHR)Principal Investigator
Anwar Muhammad ZohaibResearch Location
CanadaLead Research Institution
Simon Fraser University (Burnaby, B.C.)Research Priority Alignment
N/A
Research Category
Epidemiological studies
Research Subcategory
Disease surveillance & mapping
Special Interest Tags
Data Management and Data Sharing
Study Type
Non-Clinical
Clinical Trial Details
N/A
Broad Policy Alignment
Pending
Age Group
Not Applicable
Vulnerable Population
Not applicable
Occupations of Interest
Not applicable
Abstract
Infectious diseases as shown by the COVID-19 pandemic remain a serious threat. Genomic sequencing has revolutionized the detection and characterization of pathogens for surveillance and outbreak investigation, creating a new field of genomic epidemiology. During this ongoing pandemic, we have witnessed several gaps in establishing effective global responses that require coordinated action such as our ability to quickly adapt analytical methods to new pathogens and the ability to integrate several data sources to generate knowledge for enabling evidence-informed decision-making. In this proposed research, I aim to further this field of genomic epidemiology by developing advanced data analysis methods. Additionally, I aim to optimize these methods to be capable of adapting to datasets from various pathogens, saving time to develop again for every outbreak. Finally, I want to combine genomics and advanced data analysis (bioinformatics) to establish a method of integrating epidemiological, political, and other contextual information with genomic data to improve public health preventive measures. This project will develop a program using intersectoral genomic epidemiology to counter infectious diseases.